News

he  Last Tuesday (February 9th, 2021), the Board of the National Health Surveillance Agency (ANVISA) decided not to comment on the Senate … Brazilian National Health Surveillance Agency (ANVISA) decides not to comment on a bill that proposes changes to the Industrial Property Act

The Brazilian Patent and Trademark Office (BPTO) published on Tuesday, January 5th 2021, the first edition of the Manual of Geographical Indications. … BPTO publishes Manual on Geographical Indications

The Brazilian Patent and Trademark Office (BPTO) published, by means of Ordinance n° 404, dated December 21, 2020, phase II of the … BPTO publishes phase II of the Patent Prosecution Highway (PPH) Program

Four years after the publication of the first Examination Guidelines for computer-implemented inventions, the Brazilian Patent Office published a new revised version … New Guidelines for Examination of Patent Applications for Computer-Implemented Inventions

Although it was created in July 2019, the Brazilian Data Protection Office (ANPD) has started to show its operationalization. Two months after … Brazilian Data Protection Office’s website is on

Kasznar Leonardos is pleased to announce the promotion of three new partners, effective January 2021. Ísis Valaziane and Luciana Minada will become … New partners for Litigation and Patents

On December 2, 2020, through its Commission on Narcotics, the United Nations approved a recommendation issued by WHO – World Health Organization … UN removes Cannabis from List of Narcotic Substances

The Revised Guidelines for the Examination of Patent Applications in the Biotechnology Field (Normative Instruction INPI/PR n° 118/2020) finally entered into force … Revised Guidelines for the Examination of Patent Applications in the Biotechnology field in force

The Brazilian FDA (ANVISA) published on November 19, 2020, four manuals regarding the analysis of prior consent of patent applications related to … ANVISA published manuals related to prior consent of patent applications

Privacy and data protection have been in the spotlight in Brazil for the past seven years, ever since sensitive Brazilian government documents … Brazil’s Best Counsel 2021 – Chapter Opening: Data Protection

On November 17th, 2020, ANVISA’s Board of Directors (BoD) unanimously granted an administrative appeal for reassessment of prior consent of a patent … ANVISA decides that a patent application related to pharmaceutical use of cannabinoids is not to be deemed as against public health

As reported in our Newsletter #06, sent in March 2019, the Public Civil Action filed in 2002 by the Federal Public Prosecution … The controversy regarding amendments to patent applications in Brazil – A new chapter begins

On November 5, Anvisa published Resolution – RDC 432/2020 which sets forth an obligation to describe the list of ingredients in Portuguese … ANVISA establishes new rules for labeling of personal care products, cosmetics and perfumes

Our senior partner Rafael Lacaz Amaral authored a chapter about Brazil, first appeared in Global Patent Litigation Guide: Helping businesses navigate the … Global Patent Litigation 2021 – Brazil

Our partner and Head of Regulatory Anderson Ribeiro, together with his associates Lucas Calabria and Matheus Montecasciano, co-sign the chapter “Pharma & … Pharma & Medical Device Regulation in Brazil